interaction records 54 assistance programs 55 0 personal data stored

Generic competition · all medicines · read 12 November 2026

Is there a generic of Cocaine Hydrochloride, and who makes it?

Cocaine Hydrochloride appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Cocaine Hydrochloride1 dosage-form group in the Orange Book
0generic makers listed
  1. Cocaine Hydrochloride appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution, Nasal

Brand listed, no generic listed as marketed

Brand listed as marketed: Goprelto and Numbrino. No generic is listed as marketed.

20152020202520302035204001brand 2017data datePatent 10016407 listed to expire 7 February 2037Patent 9867815 listed to expire 7 February 2037Patent 10413505 listed to expire 7 February 2037Patent 10420760 listed to expire 7 February 2037Patent 10149843 listed to expire 7 February 2037Patent 10933060 listed to expire 7 February 2037Patent 10973811 listed to expire 7 February 2037Patent 10987347 listed to expire 7 February 2037Patent 10894012 listed to expire 7 February 2037Patent 10857095 listed to expire 7 February 2037Patent 10231961 listed to expire 7 February 2037Patent 11040032 listed to expire 7 February 2037
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 7 February 2037Patent 10016407
  • 7 February 2037Patent 9867815
  • 7 February 2037Patent 10413505
  • 7 February 2037Patent 10420760
  • 7 February 2037Patent 10149843
  • 7 February 2037Patent 10933060
  • 7 February 2037Patent 10973811
  • 7 February 2037Patent 10987347

4 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.